Spanish Red Biotech Pipeline

Agrenvec

Recombinant proteins, COVID-19 antigens

Type: Biomarkers / Diagnostic
Therapeutic area: Infections
Indication: COVID-19 antigens for immunoassay
Phase: 3Clinical validation, 2Preclinical Validation, 1R+D
Studies location: SPAIN